Panama Petrochem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 8, 2025, 3:29 am

Competitors of Panama Petrochem Ltd

All Competitor Stocks of Panama Petrochem Ltd

Quarterly Result

Last Updated: August 1, 2025, 3:55 pm

Below is a detailed analysis of the quarterly data for Panama Petrochem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 693.00 Cr.. The value appears to be declining and may need further review. It has decreased from 695.00 Cr. (Mar 2025) to 693.00 Cr., marking a decrease of 2.00 Cr..
• For Expenses, as of Jun 2025, the value is 638.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 636.00 Cr. (Mar 2025) to 638.00 Cr., marking an increase of 2.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 55.00 Cr., marking a decrease of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Mar 2025) to 53.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 20.00% (Mar 2025) to 19.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.05. The value appears to be declining and may need further review. It has decreased from 7.32 (Mar 2025) to 7.05, marking a decrease of 0.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:42 am

Growth

Last Updated: September 5, 2025, 12:05 pm

Balance Sheet

Last Updated: June 16, 2025, 11:34 am

Below is a detailed analysis of the balance sheet data for Panama Petrochem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,243.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,091.00 Cr. (Mar 2024) to 1,243.00 Cr., marking an increase of 152.00 Cr..
• For Borrowings, as of Mar 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 26.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 236.00 Cr.. The value appears to be improving (decreasing). It has decreased from 281.00 Cr. (Mar 2024) to 236.00 Cr., marking a decrease of 45.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,524.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,409.00 Cr. (Mar 2024) to 1,524.00 Cr., marking an increase of 115.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 312.00 Cr.. The value appears strong and on an upward trend. It has increased from 287.00 Cr. (Mar 2024) to 312.00 Cr., marking an increase of 25.00 Cr..
• For CWIP, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 18.00 Cr..
• For Investments, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 17.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,174.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,120.00 Cr. (Mar 2024) to 1,174.00 Cr., marking an increase of 54.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,524.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,409.00 Cr. (Mar 2024) to 1,524.00 Cr., marking an increase of 115.00 Cr..

Notably, the Reserves (1,243.00 Cr.) exceed the Borrowings (33.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Panama Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 30.92. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.92, marking a decrease of 1.34.
• For Diluted EPS (Rs.), as of Mar 25, the value is 30.92. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.92, marking a decrease of 1.34.
• For Cash EPS (Rs.), as of Mar 25, the value is 32.96. This value is within the healthy range. It has decreased from 33.88 (Mar 24) to 32.96, marking a decrease of 0.92.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 207.44. It has increased from 182.27 (Mar 24) to 207.44, marking an increase of 25.17.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 207.44. It has increased from 182.27 (Mar 24) to 207.44, marking an increase of 25.17.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 461.63. It has increased from 389.54 (Mar 24) to 461.63, marking an increase of 72.09.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 42.80. This value is within the healthy range. It has decreased from 44.39 (Mar 24) to 42.80, marking a decrease of 1.59.
• For PBIT / Share (Rs.), as of Mar 25, the value is 40.75. This value is within the healthy range. It has decreased from 42.77 (Mar 24) to 40.75, marking a decrease of 2.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 37.75. This value is within the healthy range. It has decreased from 39.80 (Mar 24) to 37.75, marking a decrease of 2.05.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 30.91. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.91, marking a decrease of 1.35.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 30.91. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.91, marking a decrease of 1.35.
• For PBDIT Margin (%), as of Mar 25, the value is 9.27. This value is below the healthy minimum of 10. It has decreased from 11.39 (Mar 24) to 9.27, marking a decrease of 2.12.
• For PBIT Margin (%), as of Mar 25, the value is 8.82. This value is below the healthy minimum of 10. It has decreased from 10.97 (Mar 24) to 8.82, marking a decrease of 2.15.
• For PBT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has decreased from 10.21 (Mar 24) to 8.17, marking a decrease of 2.04.
• For Net Profit Margin (%), as of Mar 25, the value is 6.69. This value is within the healthy range. It has decreased from 8.28 (Mar 24) to 6.69, marking a decrease of 1.59.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 8. It has decreased from 8.28 (Mar 24) to 6.69, marking a decrease of 1.59.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.90. This value is below the healthy minimum of 15. It has decreased from 17.69 (Mar 24) to 14.90, marking a decrease of 2.79.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.99. This value is within the healthy range. It has decreased from 23.17 (Mar 24) to 18.99, marking a decrease of 4.18.
• For Return On Assets (%), as of Mar 25, the value is 12.27. This value is within the healthy range. It has decreased from 13.84 (Mar 24) to 12.27, marking a decrease of 1.57.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.90. It has increased from 1.78 (Mar 24) to 1.90, marking an increase of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 5.18. This value exceeds the healthy maximum of 3. It has increased from 3.81 (Mar 24) to 5.18, marking an increase of 1.37.
• For Quick Ratio (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 2. It has increased from 2.13 (Mar 24) to 3.37, marking an increase of 1.24.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.20. This value is within the healthy range. It has increased from 5.78 (Mar 24) to 6.20, marking an increase of 0.42.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.40. This value is below the healthy minimum of 20. It has decreased from 24.79 (Mar 24) to 19.40, marking a decrease of 5.39.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.20. This value is below the healthy minimum of 20. It has decreased from 23.60 (Mar 24) to 18.20, marking a decrease of 5.40.
• For Earning Retention Ratio (%), as of Mar 25, the value is 80.60. This value exceeds the healthy maximum of 70. It has increased from 75.21 (Mar 24) to 80.60, marking an increase of 5.39.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.80. This value exceeds the healthy maximum of 70. It has increased from 76.40 (Mar 24) to 81.80, marking an increase of 5.40.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.26. This value is within the healthy range. It has decreased from 14.95 (Mar 24) to 14.26, marking a decrease of 0.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 11.87 (Mar 24) to 11.30, marking a decrease of 0.57.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,124.06. It has increased from 1,894.57 (Mar 24) to 2,124.06, marking an increase of 229.49.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.76, marking a decrease of 0.04.
• For EV / EBITDA (X), as of Mar 25, the value is 8.20. This value is within the healthy range. It has increased from 7.05 (Mar 24) to 8.20, marking an increase of 1.15.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.82, marking a decrease of 0.02.
• For Retention Ratios (%), as of Mar 25, the value is 80.59. This value exceeds the healthy maximum of 70. It has increased from 75.20 (Mar 24) to 80.59, marking an increase of 5.39.
• For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 1.84, marking an increase of 0.02.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.82, marking a decrease of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.08, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness